Credit: ivanko80/Adobe Stock
The battle over access to a key drug used for medication abortions continues to heat up, both in a Texas courtroom and in the U.S. Senate.
Today, U.S. District Judge Matthew Kacsmaryk will hear arguments today in a case involving the U.S. Food and Drug Administration's decades-old approval of the drug mifepristone, one of two medications used to terminate an early pregnancy. The plaintiffs asked Kacsmaryk to order the FDA to withdraw its approval of the drug, arguing that the agency mistakenly approved the drug under a regulation that allows accelerated approval of medications for "serious or life-threatening illnesses."
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
